21 October 2024
21 October 2024
Centiloid scoring and tau PET quantification are the two new features in the company’s syngo.PET software application.
New codes for Barostim procedures will be implemented on January 1, 2026; current Category III codes will be used until then.
The money will be used to drive the company’s AI-powered software designed to take multiple steps out of the biofabrication process.
The company’s menopause transitions kit monitors and tracks four reproductive hormones that can help evaluate hormone replacement therapy (HRT) or other menopausal treatments.
The RightAI platform aims to assist clinicians in selecting the right patients for clinical trials and make precise treatment decisions.
Nexalin’s device missed the primary endpoint but produced positive data in secondary endpoint measures.
The survey carried out by Tasso found that inconvenience was the main reason patients delay getting blood tests next to fear and anxiety.
Google Health has partnered with Forus Health, AuroLab and Perceptra, who will work on securing local regulatory approvals in India and Thailand.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
GlobalData's latest report provides comprehensive information about the Robotic Surgical Systems pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report will enable you to access significant competitor information, analysis, and insights to improve your R&D strategies, and identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage.
GlobalData's latest report provides comprehensive information about the Robotic Surgical Systems pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report will enable you to access significant competitor information, analysis, and insights to improve your R&D strategies, and identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage.
GlobalData's latest report provides comprehensive information about the Robotic Surgical Systems pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report will enable you to access significant competitor information, analysis, and insights to improve your R&D strategies, and identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage.
GlobalData's latest report provides comprehensive information about the Robotic Surgical Systems pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report will enable you to access significant competitor information, analysis, and insights to improve your R&D strategies, and identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage.
GlobalData's latest report provides comprehensive information about the Robotic Surgical Systems pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report will enable you to access significant competitor information, analysis, and insights to improve your R&D strategies, and identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage.
Give your business an edge with our leading industry insights.
